Image

Melanoma Research

Featured image for “Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma”
11/24/2020

Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “WIM: Emphasizing the Whole Patient and the Whole Physician”
06/02/2020

WIM: Emphasizing the Whole Patient and the Whole Physician

  By, Vallerie A. Malkin In August of 2017, AIM at Melanoma hosted the inaugural Women in Melanoma Initiative in…
Blog - Melanoma360
Melanoma Research
Featured image for “AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University”
01/23/2020

AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University

  January 23, 2020 (San Rafael, California)… AIM at Melanoma and AIM at Melanoma Research Foundation announce the opening of…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “AIM at Melanoma Opens The Third Branch of Fresh Frozen Primary Tissue Bank at at the Knight Cancer Institute at Oregon Health & Science University”
11/14/2019

AIM at Melanoma Opens The Third Branch of Fresh Frozen Primary Tissue Bank at at the Knight Cancer Institute at Oregon Health & Science University

  AIM AT MELANOMA OPENS THIRD BRANCH OF FRESH FROZEN PRIMARY TISSUE BANK AT THE KNIGHT CANCER INSTITUTE AT OREGON…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center”
09/09/2019

AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center

September 9, 2019 (San Rafael, California) AIM at Melanoma announces the grand opening of the second branch of the International…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “The Conversation Has Changed For Stage III Melanoma”
06/11/2019

The Conversation Has Changed For Stage III Melanoma

Stage III Melanoma—High Risk for Recurrence and (Now) Multiple Options Stage III adjuvant treatment options were for many years limited…
Blog - Melanoma360
Melanoma Research
Featured image for “AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center”
04/04/2019

AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center

April 5, 2019 (San Rafael, California)… AIM at Melanoma announces the grand opening of the first branch of the International…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma”
03/20/2019

Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma

AIM at Melanoma will very soon announce the grand opening of the first branch of the International Tissue Bank Consortium…
Blog - Melanoma360
Melanoma Research
Featured image for “Melanoma International Collaborative Adaptive Trials: Progress Report”
11/13/2018

Melanoma International Collaborative Adaptive Trials: Progress Report

The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “The Melanoma Tissue Bank: Progress Report”
11/13/2018

The Melanoma Tissue Bank: Progress Report

As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
Blog - Melanoma360
Breaking News
Melanoma Research
11/24/2020

Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
Featured image for “Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
06/02/2020

WIM: Emphasizing the Whole Patient and the Whole Physician

  By, Vallerie A. Malkin In August of 2017, AIM at Melanoma hosted the inaugural Women in Melanoma Initiative in…
Featured image for “WIM: Emphasizing the Whole Patient and the Whole Physician”
Blog - Melanoma360
 | 
Melanoma Research
01/23/2020

AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University

  January 23, 2020 (San Rafael, California)… AIM at Melanoma and AIM at Melanoma Research Foundation announce the opening of…
Featured image for “AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
11/14/2019

AIM at Melanoma Opens The Third Branch of Fresh Frozen Primary Tissue Bank at at the Knight Cancer Institute at Oregon Health & Science University

  AIM AT MELANOMA OPENS THIRD BRANCH OF FRESH FROZEN PRIMARY TISSUE BANK AT THE KNIGHT CANCER INSTITUTE AT OREGON…
Featured image for “AIM at Melanoma Opens The Third Branch of Fresh Frozen Primary Tissue Bank at at the Knight Cancer Institute at Oregon Health & Science University”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
09/09/2019

AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center

September 9, 2019 (San Rafael, California) AIM at Melanoma announces the grand opening of the second branch of the International…
Featured image for “AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
06/11/2019

The Conversation Has Changed For Stage III Melanoma

Stage III Melanoma—High Risk for Recurrence and (Now) Multiple Options Stage III adjuvant treatment options were for many years limited…
Featured image for “The Conversation Has Changed For Stage III Melanoma”
Blog - Melanoma360
 | 
Melanoma Research
04/04/2019

AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center

April 5, 2019 (San Rafael, California)… AIM at Melanoma announces the grand opening of the first branch of the International…
Featured image for “AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
03/20/2019

Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma

AIM at Melanoma will very soon announce the grand opening of the first branch of the International Tissue Bank Consortium…
Featured image for “Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma”
Blog - Melanoma360
 | 
Melanoma Research
11/13/2018

Melanoma International Collaborative Adaptive Trials: Progress Report

The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
Featured image for “Melanoma International Collaborative Adaptive Trials: Progress Report”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
11/13/2018

The Melanoma Tissue Bank: Progress Report

As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
Featured image for “The Melanoma Tissue Bank: Progress Report”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research